Further studies will be needed to determine if IP-10 changes are equally sensitive to CF APE treatment in individuals with MRSA infection in the absence of P. aeruginosa colonization, or in other populations such as individuals with non-CF chronic rhinosinusitis, since of majority of individuals in our study also harbored MRSA.” This evidence concerns the gene CXCL10 and chronic rhinosinusitis.